Numerous clinical data suggested that AD patients exhibit severe impairment of cholinergic–neurotransmitter systems, possibly due to the suppression of acetylcholine (responsible for neural synapse) by Acetylcholinesterase (AChE) activity (Birks, 2006; Grothe et al., 2013). Here, ACHE is linked to Alzheimer disease.